Customer Support: 131 242

  • Shopping Cart
    There are no items in your cart
We noticed you’re not on the correct regional site. Switch to our AMERICAS site for the best experience.
Dismiss alert

ISO 10993-3:2026

Current

Current

The latest, up-to-date edition.

Biological evaluation of medical devices — Part 3: Evaluation of genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity

Available format(s)

Hardcopy , PDF 1 User , PDF 3 Users , PDF 5 Users , PDF 9 Users

Language(s)

English, French

Published date

06-08-2026

$386.25
Including GST where applicable

This document specifies strategies for risk estimation and evaluation of biological harms with respect to:

  • genotoxicity;
  • carcinogenicity;
  • reproductive toxicity; and
  • developmental toxicity.

This document is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity has been established.

This document is not applicable to active pharmaceutical ingredients of device-drug combination products or biological components of device-biologic combination products which are covered by regulations.

NOTE Guidance on selecting relevant biological effects for medical devices is covered in ISO10993-1.

Committee
ISO/TC 194
DocumentType
Standard
Pages
41
PublisherName
International Organization for Standardization
Status
Current
Supersedes

$386.25
Including GST where applicable